- Home
- CUB vs AVIR Comparison
CUB vs AVIR Comparison
Compare CUB & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUB
- AVIR
- Stock Information
- Founded
- CUB 2024
- AVIR 2012
- Country
- CUB United States
- AVIR United States
- Employees
- CUB N/A
- AVIR N/A
- Industry
- CUB
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- CUB
- AVIR Health Care
- Exchange
- CUB NYSE
- AVIR Nasdaq
- Market Cap
- CUB 310.7M
- AVIR 273.7M
- IPO Year
- CUB 2024
- AVIR 2020
- Fundamental
- Price
- CUB $10.24
- AVIR $3.01
- Analyst Decision
- CUB
- AVIR Hold
- Analyst Count
- CUB 0
- AVIR 1
- Target Price
- CUB N/A
- AVIR $6.88
- AVG Volume (30 Days)
- CUB 23.3K
- AVIR 263.3K
- Earning Date
- CUB 01-01-0001
- AVIR 03-06-2025
- Dividend Yield
- CUB N/A
- AVIR N/A
- EPS Growth
- CUB N/A
- AVIR N/A
- EPS
- CUB N/A
- AVIR N/A
- Revenue
- CUB N/A
- AVIR N/A
- Revenue This Year
- CUB N/A
- AVIR N/A
- Revenue Next Year
- CUB N/A
- AVIR N/A
- P/E Ratio
- CUB $44.81
- AVIR N/A
- Revenue Growth
- CUB N/A
- AVIR N/A
- 52 Week Low
- CUB $9.96
- AVIR $2.75
- 52 Week High
- CUB $10.55
- AVIR $4.15
- Technical
- Relative Strength Index (RSI)
- CUB N/A
- AVIR 41.74
- Support Level
- CUB N/A
- AVIR $2.90
- Resistance Level
- CUB N/A
- AVIR $3.29
- Average True Range (ATR)
- CUB 0.00
- AVIR 0.12
- MACD
- CUB 0.00
- AVIR -0.01
- Stochastic Oscillator
- CUB 0.00
- AVIR 17.95
About CUB LIONHEART HOLDINGS
Lionheart Holdings is a blank check company.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).